Press Release
Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates
Reports second quarter revenues of $241 million, GAAP net loss of $1.3 billion and GAAP EPS of $(3.33) Updates 2024 financial framework and revises expectations for product sales to $3.0 to $3.5 billion Received U.S. FDA approval for RSV vaccine, mRESVIA, and began shipping in July; received EMA positive opinion in June Announced positive Phase 3 data for combination vaccine against influenza and COVID-19 Announced positive Phase 3 data for next-generation COVID-19 vaccine Read More
Press Release
Boy Creates AllBoss to Make Entrepreneurship Fun, Easy, and More Accessible for Kids
11-year-old boy bringing AllBoss Carts to market on Kickstarter with the help of his mom. AllBoss Carts make the daunting and time-consuming task of helping your child become a kid entrepreneur easy and fun. AllBoss carts can be set up in less than five minutes and come with colorful interchangeable branding, uniforms, and product displays ready to go right out of the box. The cart's unique slanted front is the first of it's kind and was designed for the easy viewing of cart contents. Read More
Press Release
Revolutionizing Business Growth and Innovation: BuzDev Unveils a New Era in Management Consulting
BuzDev, led by seasoned Global Technology Executive Brandon Buzarde, launches to redefine business growth and innovation through strategic partnerships and a commitment to operational excellence. Read More
Press Release
MÍRAME Fine Art Proudly Represents Olga Anaskina: Celebrating Multiculturalism in Costa Rican Contemporary Art
MÍRAME Fine Art, the premier online Costa Rican art gallery dedicated to promoting the nation's finest artists, proudly celebrates the work of artist Olga Anaskina. Promoting the nation's rich cultural heritage, MÍRAME Fine Art connects artists with art lovers worldwide. Read More
Press Release
National Security Expert Egon Cholakian Breaks Protocol to Speak About Concerning Findings in Recent Documentary 'The Impact'
Dr. A. Egon Cholakian, a national security expert and registered federal lobbyist, delivered a landmark video speech in which he presented his in-depth analysis of the growing tensions surrounding geopolitical events and provided new data on the escalating climate crisis. Read More
Press Release
Issuance of New European Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs)
New patent issued for core rare disease target indication for crofelemer Jaguar has approximately 200 patents issued and pending Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of short bowel syndrome (SBS) and microvillus inclusion disease (MVID), an ultrarare CDD, in the US, EU, and Middle East/North Africa regions, with proof-of-concept results expected before the end of 2024 and throughout 2025 Read More
Press Release
New List of Impact Investors and Their Data Published in the Financial Times Aims to Mobilize Mainstream Investors
Highlighting 100+ investors and their assets under management dedicated to impact investing, the Global Impact Investing Network and the Financial Times provide investors with information and inspiration to accelerate the mobilization of capital to solve the world's most pressing problems. Read More
Press Release
Rally OurBus Supports Urban Mobility and Endorses Congestion Pricing Plan for Manhattan
Rally founder Numaan Akram, a mass mobility leader, advocates for the recently paused congestion pricing plan and offers solutions for Manhattan's transit dilemma, including bus rideshares. Read More
Press Release
